Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 May 2010

Esposito Susanna, Molteni Claudio G, Colombo Carla, Daleno Cristina, Daccò Valeria, Lackenby Angie, Principi Nicola

Abstract excerpt

BACKGROUND: Oseltamivir is considered the drug of choice for patients with pandemic influenza for whom drug treatment is recommended because adamantanes seem to be ineffective against pandemic A/H1N1 influenza virus and zanamivir is contraindicated in people with underlying respiratory conditions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza A Virus, H1N1 Subtype

Share to Influenza, Human

Share to Oseltamivir

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Share to Zanamivir

Source

Identifiers

PMID: 20335065
DOI: 10.1016/j.jcv.2010.02.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20335065-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.PMID 20335065Read ↗

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.Semantic proximity Read ↗

Detection and management of antiviral resistance for influenza virusesSemantic proximity Read ↗

Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.Semantic proximity Read ↗

Recovery of a Multidrug‐Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with OseltamivirSemantic proximity Read ↗

Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.Semantic proximity Read ↗

Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza.Semantic proximity Read ↗

Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.Semantic proximity Read ↗

Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza.Semantic proximity Read ↗

Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.Semantic proximity Read ↗

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.Semantic proximity Read ↗

Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.Semantic proximity Read ↗

Influenza virus susceptibility and resistance to oseltamivir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.